SISCAPA Assay Technologies Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
2ndary - Private
SISCAPA Assay Technologies General Information
Description
Developer of protein-based technology designed for the adoption of multiplex test panels for clinical use. The company's tools combine antibody-based peptide enrichment with quantitative mass spectrometry to provide accurate quantitation of target proteins as well as provides analysis using a generic workflow, enabling researchers to understand longitudinal changes in health and disease using simplified sample acquisition methods such as dried blood spots.
Contact Information
Website
www.siscapa.comCorporate Office
- 1759 Willard Street Northwest
- Unit 3
- Washington, DC 20009
- United States
Corporate Office
- 1759 Willard Street Northwest
- Unit 3
- Washington, DC 20009
- United States
SISCAPA Assay Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 11-Apr-2014 | Completed | Startup | |||
| 1. Angel (individual) | 23-Aug-2012 | $562K | $562K | Completed | Startup |
SISCAPA Assay Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
SISCAPA Assay Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SISCAPA Assay Technologies Patents
SISCAPA Assay Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3238472-A1 | Enriched peptide detection by single molecule sequencing | Pending | 01-Dec-2021 | ||
| AU-2022400954-A1 | Enriched peptide detection by single molecule sequencing | Pending | 01-Dec-2021 | ||
| EP-4441277-A2 | Enriched peptide detection by single molecule sequencing | Pending | 01-Dec-2021 | ||
| US-20220273209-A1 | Devices and methods for sample collection | Pending | 29-Jul-2019 | ||
| EP-4004543-A1 | Devices and methods for sample collection | Inactive | 29-Jul-2019 | A61B5/150305 |
SISCAPA Assay Technologies Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Leigh Anderson Ph.D | Co-Founder, Board Member & Chief Executive Officer | |
| Terry Pearson Ph.D | Co-Founder, Chief Scientific Officer & Board Member | |
| Constance Seniff | Co-Founder, Vice President, Business Operation, Chief Operating Officer & Board Member |
SISCAPA Assay Technologies Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Constance Seniff | SISCAPA Assay Technologies | Co-Founder, Vice President, Business Operation, Chief Operating Officer & Board Member | |
| Guo liang Yu Ph.D | Self | Board Member | |
| Gustavo Salem | Self | Board Member | |
| Leigh Anderson Ph.D | SISCAPA Assay Technologies | Co-Founder, Board Member & Chief Executive Officer | |
| Terry Pearson Ph.D | SISCAPA Assay Technologies | Co-Founder, Chief Scientific Officer & Board Member |
SISCAPA Assay Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SISCAPA Assay Technologies FAQs
-
When was SISCAPA Assay Technologies founded?
SISCAPA Assay Technologies was founded in 2011.
-
Who is the founder of SISCAPA Assay Technologies?
Leigh Anderson Ph.D, Terry Pearson Ph.D, and Constance Seniff are the founders of SISCAPA Assay Technologies.
-
Who is the CEO of SISCAPA Assay Technologies?
Leigh Anderson Ph.D is the CEO of SISCAPA Assay Technologies.
-
Where is SISCAPA Assay Technologies headquartered?
SISCAPA Assay Technologies is headquartered in Washington, DC.
-
What is the size of SISCAPA Assay Technologies?
SISCAPA Assay Technologies has 11 total employees.
-
What industry is SISCAPA Assay Technologies in?
SISCAPA Assay Technologies’s primary industry is Biotechnology.
-
Is SISCAPA Assay Technologies a private or public company?
SISCAPA Assay Technologies is a Private company.
-
What is SISCAPA Assay Technologies’s current revenue?
The current revenue for SISCAPA Assay Technologies is .
-
How much funding has SISCAPA Assay Technologies raised over time?
SISCAPA Assay Technologies has raised $1.56M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
